whereas the severity of spontaneous chronic nephropathy in treated male rats relative to controls increased from 52 and 104 weeks.
As a result of the current discussion in the literature (3), the kidney specimens were reanalyzed for the hallmarks of x2u-globulin nephropathy sequelae, namely the presence of granular casts and linear mineralization (8) . These changes were not observed in male rats receiving 250, 1,000, or 2,000 mg/kg of gabapentin for 2 years. In terms of proliferative effects, there were 3 foci of atypical hyperplasia of renal tubules: 2/50 were found in male rats at 1,000 mg/kg and 1/50 male rats at 2,000 mg/kg of gabapentin. These kidney examinations in the 2-year study included four sections (two from each kidney) from every animal in the group (50/sex/group), amounting to 1,600 kidney sections in the 2-year rat study. This standard procedure seems to adequately sample the kidney.
Reference was made to renal accumulation of gabapentin and to its ability to bind a2u-globulin. Metabolic disposition data revealed no differences in the accumulation of gabapentin in the kidney of male and female rats. Gabapentin distributes rapidly to the kidney in both sexes, and approximately 10-12% of the dose is found at 2-hr post-dose. The elimination decay is rapid, and 0.20-0.14 gabapentin radioequivalents in micrograms per gram are found at 12 hr post-dose. Full (6) attributed the elevated risk of renal cell cancer in humans exposed to gasoline "to the tetraethyl-lead content of the gasoline and not to the gasoline (volatile hydrocarbons) itself." That is wrong. Partanen et al. (6) actually wrote that "our results suggest that some hydrocarbon constituents) or additives) of gasoline are conducive to renal cell cancer in humans," and although "tetraethyl lead is capable of dermal entrance . .. the amount of lead intake is probably low in the jobs with typical dermal exposure to gasoline." Furthermore, a recent epidemiological study of workers exposed to gasoline vapors (service station workers in the Nordic countries) found a 30% excess risk of kidney cancer with no excess risk of leukemia (7) . The kidney cancer findings in humans exposed to gasoline vapors correspond to previously reported kidney cancer findings in male rats, which Dietrich ironically dismisses as irrelevant to human risk because of a2u-globulin accumulation.
Second, Dietrich attempts to explain the nonconcordance between lindane-induced a2u-globulin nephropathy and the lack of a male rat kidney tumor response by speculating about relationships among exposure to lindane, testicular atrophy, serum testosterone levels, and a2u-nephropathy.
Dietrich and Swenberg (8) reported that a daily dose of 10 mg/kg lindane induces a "marked increase in a2u-globulin" in the kidney of male F344 rats. The National Cancer Institute's carcinogenicity feed study on lindane found no increase in kidney cancer or testicular atrophy in dosed rats compared to controls (91S. Conversely, in a separate review of that study, Reuber (10) reported that the incidences of moderate and severe testicular atrophy were increased in the 472 ppm dose group (equivalent to 20 mg/kg/day) but not in the 236 ppm dose group (equivalent to 10 mg/kg/day) and that the incidence and severity of chronic renal disease, but not kidney cancer, was increased in both dose groups of male rats. Thus, lindane did not induce kidney tumors in male rats at a dose that caused a marked increase in renal a2u-globulin accumulation and that was not associated with testicular atrophy. Furthermore, there are no data available on the effects of lindane on testosterone production in Leydig cells or on dose-response relationships between testicular atrophy in rats treated with lindane, serum testosterone levels, and effects on hepatic a2u-globulin synthesis. In spite of this limitation, Dietrich did not hesitate to conclude why this a2u-binding compound did not induce kidney tumors: "Based on the assumption that high levels of a2u-globulin could not have been maintained in male rats treated with high doses of lindane in the 2-year bioassay, due to testicular atrophy and thus a lack of testosterone, it becomes obvious why renal tumors did not develop in lindane-treated male rats." We believe that "obvious conclusions" should be based on data rather than assumptions. Indeed, alternative explanations (e.g., a2u-globulin accumulation is not predictive of kidney tumor response) are compatible with available data and should be tested experimentally.
Third, Dietrich has misrepresented the findings of Green et al. (11) on the influence of a2u-globulin accumulation in the renal carcinogenicity of perchloroethylene in male rats. In an inhalation study of perchloroethylene by the National Toxicology Program, renal tubular cell neoplasms were induced in male rats exposed to 200 or 400 ppm (12) . In their studies on the mechanisms of tumor induction by perchloroethylene, Green et al. (11) reported that "this response [accumulation of protein droplets (c2u-globulin) in the P2 segment of the kidney proximal tubules] was not seen after inhalation exposure to 400 ppm perchloroethylene for 28 days and hence may not be associated with the tumors seen at this dose level." Rather than noting the actual findings of this study, Dietrich chose to exaggerate Green's inferences by claiming that "the tumors observed in the male rat kidney appear to be related to a combination of at least two mechanisms: genotoxicity from the P-lyase pathway and the a2u-globulin mechanism." This is a scientifically unjustified conclusion.
Has the x2u-globulin hypothesis been "meticulously proven" as claimed by Dietrich? One attempt to develop a dosimetry model based on the cx2u-globulin hypothesis and which includes synthesis, excretion, degradation, and renal accumulation of x2u-globulin has been reported (13) . However, this model was not able to simulate the renal accumulation of a2u-globulin in male rats dosed with 2,4,4-trimethyl-2-pentanol, even when the renal degradation rate of the a~2u-ligand complex was assumed to be inhibited beyond what has been reported in the literature [100% inhibition rather than the 30% inhibition reported by Lehman-McKeeman et al. (14) ]. Because this test of the a2u-globulin hypothesis (the only one performed to date) could not reproduce the critical quantitative relationships between exposure to an a2u-binding ligand and ct2u-globulin accumulation observed in the male rat kidney, development of alternative hypotheses based on the same available information is necessary. Interestingly, Dietrich overlooked this important study by Borghoff et al. (13) in citing data to support the a2u-globulin hypothesis. We agree with the views of de la Iglesia et al. (15) that "clearly new data, rather than new assumptions, will give fresh insight to our understanding of the a2u nephropathy puzzle." Dietrich and others (16) take the position of declaring that conclusions by original investigators should be accepted as valid, whereas alternative interpretations of the same data by other scientists (17) are distortions of fact. Unfortunately, incorrect speculations by original investigators are not rare. When this possibility exists and the consequences of misinterpretation can adversely affect public health, then it is incumbent on responsible scientists to present their perspectives. For those who care about public health, this is good enough reason to question the validity of "accepted" mechanisms. Furthermore, scientific advancement is based on the principle of rigorous hypothesis testing. To accept and promote unproven hypotheses as fact is equivalent to elevating hypotheses to the level of actual data. This is harmful for the advancement of science. Contrary to the view ofAshby (18) , we hold firm that there can be no compromise on this issue. One serious result of uncritical acceptance of hypotheses is that experiments aimed at identifying mechanistic details may not be performed. A consequence of this practice is to denigrate toxicology as a scien-
